Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-19T05:46:28.551Z Has data issue: false hasContentIssue false
  • English
  • Français

A dosimetric evaluation of a novel technique using abutted radiation fields for myeloablative total body irradiation

Published online by Cambridge University Press:  14 December 2020

Arun Chairmadurai Open the ORCID record for Arun Chairmadurai [Opens in a new window] ,
Raghul Ramiya Jayabalan ,
Thirumal Mani ,
Abhishek Gulia ,
Hari Mohan Agrawal ,
Rekha Arya ,
Esha Kaul  and
Nivedita Dhingra
Arun Chairmadurai*
Affiliation:
Department of Radiation Oncology, Jaypee Hospital, Noida, India Amity Centre for Radiation Biology, Amity University, Noida, India
Raghul Ramiya Jayabalan
Affiliation:
Department of Radiation Oncology, Jaypee Hospital, Noida, India
Thirumal Mani
Affiliation:
Department of Radiation Oncology, Jaypee Hospital, Noida, India
Abhishek Gulia
Affiliation:
Department of Radiation Oncology, Jaypee Hospital, Noida, India
Hari Mohan Agrawal
Affiliation:
Department of Radiation Oncology, Jaypee Hospital, Noida, India
Rekha Arya
Affiliation:
Department of Radiation Oncology, Jaypee Hospital, Noida, India
Esha Kaul
Affiliation:
Department of Hemato-Oncology (BMT), Jaypee Hospital, Noida, India
Nivedita Dhingra
Affiliation:
Department of Hemato-Oncology (BMT), Jaypee Hospital, Noida, India
*
Author for correspondence: Arun Chairmadurai, Department of Radiation Oncology, Jaypee Hospital, Noida, 201304, India. Tel: +91 9958198500. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

The present study reports myeloablative total body irradiation (TBI) on an isocentrically mounted linac by laying the patient on the floor and management of abutting radiation fields and partial shielding of lungs. Dosimetrical efficacy of this novel technique was evaluated.

Materials and methods:

In this retrospective study, dosimetrical parameters from TBI plans on whole-body CT scans of 46 patients were analysed. The prescribed dose to TBI was 12 Gy in six fractions delivered over a period of 3 days for myeloablative conditioning. TrueBeam STx platform Linac (Varian Medical Systems Inc., Palo Alto, CA, USA) was used to deliver opposing fields. Radiation fields were abutted to form a single large field using an arithmetic formula at source-to-skin-distance of 210 cm.

Results:

Discrepancies in dose calculated by treatment planning system were within 1·6% accuracy, and dose profile at the junction of abutting radiation fields was reproduced within 3·0% accuracy. The real treatment time for each patient was ~30 minutes/fraction. Monitor unit was weighted for multiple sub-fields to achieve dose homogeneity within 5·0% throughout the whole body, and the mean dose to lung was ≤10 Gy.

Conclusion:

Our abutting radiation field technique for myeloablative TBI is feasible in any existing linac bunker. ‘Island-blocking’ is feasible in this technique using multi-leaf collimator. This technique is cost-effective as it does not require any costly equipment than the readily available equipment in any radiotherapy facility. In general, TBI requires laborious planning procedures and spacious linac bunkers; this novel technique has the potential to change previously held notions.

Keywords

abutting radiation fieldsIsland-blocklung shield using multi-leaf collimatormyeloablative conditioningtotal body irradiation
Type
Original Article
Information
Journal of Radiotherapy in Practice , Volume 21 , Issue 2 , June 2022 , pp. 200 - 207
Check for updates
Copyright
© The Author(s), 2020. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Wong, JYC, Filippi, AR, Dabaja, BS, Yahalom, J, Specht, L. Total body irradiation: guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys 2018; 101: 521–529.CrossRefGoogle Scholar
Yuda, S, Fuji, S, Onishi, A et al. Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2019; 25: 1152–1157.CrossRefGoogle ScholarPubMed
Gao, RW, Weisdorf, DJ, DeFor, TE, Ehler, E, Dusenbery, KE. Influence of total body irradiation dose rate on idiopathic pneumonia syndrome in acute leukemia patients undergoing allogeneic hematopoietic cell transplantation. Int J Radiat Oncol Biol Phys 2019; 103: 180–189.CrossRefGoogle ScholarPubMed
Buchali, A, Feyer, P, Groll, J, Massenkeil, G, Arnold, R, Budach, V. Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation. Radiother Oncol 2000; 54: 157–162.CrossRefGoogle ScholarPubMed
Valls, A, Grañena, A, Carreras, E, Ferrer, E, Algara, M. Total body irradiation in bone marrow transplantation: fractionated vs single dose. Acute toxicity and preliminary results. Bull Cancer 1989; 76: 797–804.Google ScholarPubMed
Benyunes, MC, Sullivan, KM, Deeg, HJ et al. Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation. Int J Radiat Oncol Biol Phys 1995; 32: 661–670.CrossRefGoogle ScholarPubMed
Tauchmanovà, L, Selleri, C, Rosa, GD et al. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer 2002; 95: 1076–1084.CrossRefGoogle ScholarPubMed
Gerstein, J, Meyer, A, Sykora, KW, Frühauf, J, Karstens, JH, Bremer, M. Long-term renal toxicity in children following fractionated total-body irradiation (TBI) before allogeneic stem cell transplantation (SCT). Strahlenther Onkol 2009; 185: 751–755.CrossRefGoogle Scholar
Abboud, I, Porcher, R, Robin, M et al. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009; 15: 1251–1257.CrossRefGoogle ScholarPubMed
Girinsky, T, Benhamou, E, Bourhis, JH et al. Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. J Clin Oncol 2000; 18: 981–986.CrossRefGoogle ScholarPubMed
Labar, B, Bogdanić, V, Nemet, D et al. Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation. Bone Marrow Transplant 1992; 9: 343–347.Google ScholarPubMed
Pinnix, CC, Smith, GL, Milgrom, S et al. Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 2015; 92: 175–182.CrossRefGoogle ScholarPubMed
Fog, LS, Hansen, VN, Kjær-Kristoffersen, F et al. A step and shoot intensity modulated technique for total body irradiation. Tech Innov Patient Support Radiat Oncol 2019; 10: 1–7.Google ScholarPubMed
Hui, SK, Das, RK, Thomadsen, B, Henderson, D. CT-based analysis of dose homogeneity in total body irradiation using lateral beam. J Appl Clin Med Phys 2004; 5: 71–79.CrossRefGoogle ScholarPubMed
Hui, SK, Kapatoes, J, Fowler, J et al. Feasibility study of helical tomotherapy for total body or total marrow irradiation. Med Phys 2005; 32: 3214–3224.CrossRefGoogle ScholarPubMed
Zhuang, AH, Liu, A, Schultheiss, TE, Wong, JY. Dosimetric study and verification of total body irradiation using helical tomotherapy and its comparison to extended SSD technique. Med Dosim 2010; 35: 243–249.CrossRefGoogle ScholarPubMed
Springer, A, Hammer, J, Winkler, E et al. Total body irradiation with volumetric modulated arc therapy: dosimetric data and first clinical experience. Radiat Oncol 2016; 11: 46.CrossRefGoogle ScholarPubMed
Sun, R, Cuenca, X, Itti, R et al. First French experiences of total body irradiations using helical TomoTherapy®. Cancer Radiother 2017; 21: 365–372.CrossRefGoogle Scholar
Hong, CS, Kim, MJ, Kim, J et al. Feasibility of hybrid TomoHelical- and TomoDirect-based volumetric gradient matching technique for total body irradiation. Radiat Oncol 2019; 14 (1): 233.CrossRefGoogle ScholarPubMed
Aydogan, B, Yeginer, M, Kavak, GO, Fan, J, Radosevich, JA, Gwe-Ya, K. Total marrow irradiation with RapidArc volumetric arc therapy. Int J Radiat Oncol Biol Phys 2011; 81: 592–599.CrossRefGoogle ScholarPubMed
Fogliata, A, Cozzi, L, Clivio, A et al. Preclinical assessment of volumetric modulated arc therapy for total marrow irradiation. Int J Radiat Oncol Biol Phys 2011; 80: 628–636.CrossRefGoogle ScholarPubMed
Han, C, Schultheisss, TE, Wong, JY. Dosimetric study of volumetric modulated arc therapy fields for total marrow irradiation. Radiother Oncol 2012; 102: 315–320.CrossRefGoogle ScholarPubMed
Symons, K, Morrison, C, Parry, J, Woodings, S, Zissiadis, Y. Volumetric modulated arc therapy for total body irradiation: a feasibility study using Pinnacle3 treatment planning system and Elekta Agility™ linac. J Appl Clin Med Phys 2018; 19: 103–110.CrossRefGoogle ScholarPubMed
Losert, C, Shpani, R, Kießling, R et al. Novel rotatable tabletop for total-body irradiation using a linac-based VMAT technique. Radiat Oncol 2019; 14 (1): 244.CrossRefGoogle ScholarPubMed